Search results for "Sclerosis"

showing 10 items of 1583 documents

Genetic analysis of familial Alzheimer’s disease, primary lateral sclerosis and paroxysmal kinesigenic dyskinesia: a tool to uncover common mechanist…

2021

Tesis doctoral 270 p. figuras y tablas

paroxysmal kinesigenic dyskinesiaamyotrophic lateral sclerosisUNESCO::CIENCIAS DE LA VIDAWhole exome sequencingParoxysmal kinesigenic dyskinesiaNnsense mediated mRNA decayalzheimer's diseaseAlzheimer's diseaseAmyotrophic lateral sclerosis:CIENCIAS DE LA VIDA [UNESCO]whole exome sequencingnonsense mediated mRNA decay
researchProduct

Evaluación de los signos precoces de aterosclerosis en niños con Diabetes Mellitus tipo 1

2015

INTRODUCCIÓN La Diabetes Mellitus tipo 1 (DM1) representa un importante factor de riesgo de enfermedad cardiovascular. La ecografía de la arteria carótida común derecha se ha establecido como una técnica útil y fiable para valorar la presencia de cambios ateroscleróticos subclínicos. Estos signos precoces se manifiestan con el aumento del índice grosor íntima-media carotídeo (GIMc). Previamente a esta alteración estructural, se afecta la función endotelial, que se valora mediante la estimación de los parámetros de rigidez arterial. OBJETIVOS Evaluar el GIMc y los índices de rigidez arterial, en una población de niños con DM1, en comparación con una población de niños sanos, de similares eda…

pediatriarigidez arterialdiabetes mellitus tipo 1aterosclerosisUNESCO::CIENCIAS MÉDICASgrosor intima-media carotideo:CIENCIAS MÉDICAS [UNESCO]
researchProduct

Clinical features and disease out come in patients with pediatric and young adult onset Multiple Sclerosis

2012

pediatric Multiple sclerosis young onsetSettore MED/26 - Neurologia
researchProduct

Peroxisome Proliferator-Activated Receptors and Atherosclerosis

2011

The peroxisome proliferator-activated receptors (PPARs) represent the family of 3 nuclear receptor isoforms-PPARα, -γ, and -δ/β, which are encoded by different genes. As lipid sensors, they are primarily involved in regulation of lipid metabolism and subsequently in inflammation and atherosclerosis. Atherosclerosis considers accumulation of the cells and extracellular matrix in the vessel wall leading to the formation of atherosclerotic plaque, atherothrombosis, and other vascular complications. Besides existence of natural ligands for PPARs, their more potent synthetic ligands are fibrates and thiazolidindiones. Future investigations should now focus on the mechanisms of PPARs activation, …

peroxisome proliferator-activated receptors gammaPeroxisome proliferator-activated receptor gammamedicine.medical_specialtyPeroxisome Proliferator-Activated Receptorsperoxisome proliferator-activated receptors alphaInflammationatherosclerotic plaque030204 cardiovascular system & hematology03 medical and health sciencesatherosclerosi0302 clinical medicineInternal medicineHumansMedicineReceptorHypolipidemic Agents030304 developmental biology0303 health sciencesbusiness.industryFibric Acidsperoxisome proliferator-activated receptors γLipid metabolismPeroxisomeAtherosclerosisLipid Metabolismperoxisome proliferator-activated receptors α3. Good healthEndocrinologyNuclear receptorCancer researchlipids (amino acids peptides and proteins)Peroxisome proliferator-activated receptor alphaatherosclerosismedicine.symptomSignal transductionCardiology and Cardiovascular MedicinebusinessSignal TransductionAngiology
researchProduct

Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis.

2003

Inflammation underlies both onset and perpetuation of atherosclerosis. Plasma lipoproteins transport the platelet-activating factor-acetylhydrolase (PAF-AH) with potentially anti-inflammatory activities. Our aim was to determine whether PAF-AH activity was associated with inflammatory markers and with coronary artery disease (CAD). PAF-AH activity and a panel of inflammatory mediators were measured in plasma of 496 patients with CAD and in 477 controls; 276 patients presented with stable angina pectoris and 220 with acute coronary syndrome (ACS). Individuals within the highest quartile of PAF-AH activity had an 1.8-fold increase in CAD risk [95% confidence interval (CI), 1.01 to 3.2; P = 0.…

platelet-activating factorAdultMaleRiskmedicine.medical_specialtyAcute coronary syndromePAF acetylhydrolaseStatinCross-sectional studymedicine.drug_classMutation MissenseInflammationAngiotensin-Converting Enzyme InhibitorsQD415-436Coronary Artery DiseaseBiochemistryCoronary artery diseaseEndocrinologySex FactorsRisk FactorsInternal medicinemedicineHumansAgedInflammationbusiness.industryCell BiologySyndromeMiddle Agedmedicine.diseaseConfidence intervalCross-Sectional StudiesQuartile1-Alkyl-2-acetylglycerophosphocholine EsteraseAcute DiseaseCardiologylipids (amino acids peptides and proteins)Femaleatherosclerosismedicine.symptombusinessJournal of lipid research
researchProduct

PMN membrane fluidity, cytosolic Ca2+ content and beta2-integrin pattern in vascular atherosclerotic disease

2010

polymorphonuclear leukocyte adhesion molecules atherosclerosis
researchProduct

INFLUENZA DELL’ATEROSCLEROSI CAROTIDEA PRECLINICA SUGLI EVENTI CEREBRO- E CARDIOVASCOLARI IN 5 ANNI DI FOLLOW-UP. INFLUENCE OF PRECLINICAL CAROTID AT…

2009

Introduzione: numerosi studi hanno utilizzato la valutazione dello spessore intima-media carotideo (IMT) come marker di aterosclerosi (ATS) preclinica ed è stato ampiamente dimostrato che l’IMT correla con la presenza di ATS coronarica ed è predittivo di eventi sia cardio- che cerebrovascolari. Scopo dello studio: valutare se in soggetti asintomatici la presenza di ATS carotidea preclinica, ispessimento medio intimale carotideo (IMT) e placca carotidea asintomatica (PCA), aggiunga ulteriori informazioni nella stratificazione del rischio permettendo di individuare soggetti che potrebbero beneficiare di un trattamento più aggressivo, anche farmacologico, dei fattori di rischio presenti. Mater…

preclinical carotid atherosclerosis global cardiovascular risk primary prevention follow-up ecocolordoppler duplex scanning
researchProduct

Severity of biomedical variables associated with the course of multiple sclerosis and levels of mental resiliency

2022

Wstęp: Stwardnienie rozsiane (sclerosis multiplex – SM) to postępująca choroba demielinizacyjna ośrodkowego układu nerwowego, która może prowadzić do znacznej niepełnosprawności. Prężność psychiczna jest zasobem osobistym, który ułatwia radzenie sobie w trudnych sytuacjach, takich jak nieuleczalna choroba przewlekła. Celem pracy była weryfikacja związku między stopniem niepełnosprawności, zmiennymi biomedycznymi i prężnością u pacjentów z SM. Materiał i metody: W badaniu zastosowano Rozszerzoną skalę niepełnosprawności (EDSS), Skalę niesprawności neurologicznej szpitala Guy (GNDS) oraz Skalę pomiaru prężności (SPP-25) w celu weryfikacji związku między niepełnosprawnością neurologiczną a prę…

prężnośćniepełnosprawnośćdisabilityresiliencystwardnienie rozsianechoroba przewlekłamultiple sclerosischronic illnessNeuropsychiatria i Neuropsychologia
researchProduct

Aspectos psicológicos y neuropsicológicos de la esclerosis múltiple

2018

INTRODUCCIÓN La Esclerosis Múltiple (EM) es una enfermedad de naturaleza desmielinizante y curso crónico, cuya base anatomopatológica se caracteriza por un proceso de destrucción de las vainas de mielina que recubren los axones neuronales (manifestándose en forma de lesiones distribuidas extensamente en el parénquima cerebral y la médula espinal), lo que propiciaría una alteración en los mecanismos sinápticos y la emergencia de los síntomas característicos de la misma. Se trata de una neuropatología que se diagnostica habitualmente al final de la segunda década de la vida o inicio de la tercera, con una prevalencia superior entre las mujeres (2:1). Supone, además, una de las principales cau…

psicologíaesclerosis múltiplepsicología clínica:PSICOLOGÍA [UNESCO]psicología de la saludUNESCO::PSICOLOGÍA
researchProduct

Quantitative EEG differentiates multiple sclerosis with and without cognitive impairment from healthy controls at the beginning of the disease: preli…

2018

Background and aims: The present study aims to assess possible qEEG differences between newly diagnosed multiple sclerosis (MS) patients with or without cognitive impairment (CI). Methods: We enrolled 22 patients (18-55-years-old) treated with first-line drugs for <6 months, and 11 healthy controls. All subjects underwent neuropsychological assessment including BICAMS and BDI. EEG recordings were performed during a cognitive task (computerised “SDMT” subtest of BICAMS) and at rest. Based on neuropsychological assessment, patients were considered as affected (MSCI group) or not (MS group) by cognitive impairment. We analysed data comparing MSCI patients matched by sex, age (±5years) and e…

qEEG MS power spectrum analysis Cognitive impairmentmultiple sclerosis quantitative EEG cognitive impairmentSettore MED/26 - NeurologiaSettore BIO/09 - Fisiologia
researchProduct